More than 15,000 people arriving in Boston for the Biotechnology Industry Organization convention opening Monday will see a Massachusetts life sciences sector that has grown and changed noticeably since the city last played host to BIO in 2007.
Big drug companies, aka Big Pharma, have claimed a larger role, adding the resources of global giants to a home-grown biomedical cluster that already included over a dozen teaching hospitals, one of the nation’s largest concentrations of venture capital firms, and about 500 biotech companies working on a pipeline of approximately 900 medicines, according to figures set to be released at BIO this week by the PricewaterhouseCoopers accounting and consulting firm.
Comments
Sanofi paid 20 billion not 20 million